Plain-English translation of NCT06278428 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study aims to understand the genetic causes of severe epilepsy that starts very early in life—before age 2. Researchers will collect genetic samples and health information from infants with certain types of early-onset epilepsy to identify which genes are involved. By understanding these genetic causes, doctors hope to eventually offer better, more personalized treatment options for affected children.
Many infants with severe early-onset epilepsy have a genetic cause, but these genes are not yet fully understood. Knowing which genes are responsible could help doctors choose the right medications and interventions earlier, potentially improving outcomes and preventing developmental delays and autism-related challenges that often accompany this condition.
You likely qualify if…
You likely don't qualify if…
If your child is enrolled, you will be asked to provide a genetic sample (usually a small blood sample) from your child and possibly from parents as well. Researchers will review your child's medical records and development over time. You will need to maintain contact with the research team for at least 6 months, with follow-up visits or check-ins to monitor your child's progress and seizure control.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Vietnam